SELLAS Life Sciences Group, Inc. (SLS)

4.735 +0.24 (+5.22%) USD  |  NASDAQ  |  Feb 24, 16:00
4.76 +0.02 (+0.53%) After-Hours: 20:00
More

SELLAS Life Sciences Group Net Interest Income (Quarterly)

Net Interest Income (Quarterly) Chart

View Net Interest Income (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Interest Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Interest Income (Quarterly) Range, Past 5 Years

View Net Interest Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Interest Income (Quarterly) Benchmarks

View Net Interest Income (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. --
Geron Corp. --
Vanda Pharmaceuticals, Inc. --
ADMA Biologics, Inc. --